PMGC Holdings (ELAB) Prepaid Assets (2022 - 2026)
PMGC Holdings (ELAB) posted Prepaid Assets of $502535.0 for Q1 2026, up 428.38% sequentially from $95108.0 in Q4 2025, and down 40.33% YoY from $842199.0 in Q1 2025.
PMGC Holdings (ELAB) Prepaid Assets (2022 - 2026) Analysis & Trends
PMGC Holdings has reported Prepaid Assets for 5 years, with the latest figure at $502535.0 in Q1 2026.
- Quarterly Prepaid Assets fell 40.33% year-over-year to $502535.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $502535.0 (down 40.33% YoY) and the FY2025 annual result came in at $95108.0, down 89.05% from the prior year.
- Prepaid Assets advanced to $502535.0 in Q1 2026 per ELAB's latest filing, from $95108.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $292.1 million in Q3 2023 and troughed at $95108.0 in Q4 2025.
- A 5-year average of $25.0 million and a median of $816627.0 in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets soared 487.96% in 2023, then plunged 99.73% in 2024.
- Over 5 years, Prepaid Assets stood at $153422.0 in 2022, then jumped by 487.96% to $902053.0 in 2023, then declined by 3.72% to $868464.0 in 2024, then plunged by 89.05% to $95108.0 in 2025, then jumped by 428.38% to $502535.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $502535.0, $95108.0, and $770098.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PMGC Holdings | 31.22 Mn | 12.43 Mn | 385,691.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 502,535.00 |
| Dec 31, 2025 | 95,108.00 |
| Sep 30, 2025 | 770,098.00 |
| Jun 30, 2025 | 791,055.00 |
| Mar 31, 2025 | 842,199.00 |
| Dec 31, 2024 | 868,464.00 |
| Sep 30, 2024 | 787,848.00 |
| Jun 30, 2024 | 923,444.00 |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 902,053.00 |
| Sep 30, 2023 | 292.06 Mn |
| Dec 31, 2022 | 153,422.00 |